Civic Intelligence

Path Vaccine Solutions

990 • Fiscal year 2017 • EIN 83-0431851

Jan 01, 2017 to Dec 31, 2017 • Filed on Nov 12, 2018

2201 Westlake Avenue No 200Seattle, WA 98121

(206) 285-3500

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

41st percentile

0.21x

Higher debt load relative to assets than 41% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Liabilities / Revenue

83rd percentile

1.98x

Higher debt load relative to revenue than 83% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Net Margin

1st percentile

-515%

Higher net margin than 1% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2017

Asset Growth

1st percentile

-38%

Faster asset growth than 1% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2016 to 2017

Revenue Growth

76th percentile

19%

Faster revenue growth than 76% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2016 to 2017

Assets

Down

$66,391,789

Down $41,073,718 (-38%) from 2016

Net Assets

Down

$52,348,824

Down $39,313,282 (-43%) from 2016

Liabilities

Down

$14,042,965

Down $1,760,436 (-11%) from 2016

Revenue

Up

$7,108,916

Up $1,118,413 (+19%) from 2016

Expenses

Up

$43,734,346

Up $1,661,573 (+3.9%) from 2016

Net Income

Down

-$36,625,430

Down $543,160 (-1.5%) from 2016

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200M$150M$100M$50M$0Assets 2010: $151,102,797Liabilities 2010: $4,781,234Net Assets 2010: $146,321,5632010Assets 2011: $133,507,981Liabilities 2011: $6,691,219Net Assets 2011: $126,816,7622011Assets 2012: $142,045,531Liabilities 2012: $2,850,743Net Assets 2012: $139,194,7882012Assets 2013: $166,859,076Liabilities 2013: $6,024,155Net Assets 2013: $160,834,9212013Assets 2014: $149,044,550Liabilities 2014: $10,278,308Net Assets 2014: $138,766,2422014Assets 2015: $150,830,465Liabilities 2015: $4,059,847Net Assets 2015: $146,770,6182015Assets 2016: $107,465,507Liabilities 2016: $15,803,401Net Assets 2016: $91,662,1062016Assets 2017: $66,391,789Liabilities 2017: $14,042,965Net Assets 2017: $52,348,8242017Assets 2018: $38,472,788Liabilities 2018: $37,875,254Net Assets 2018: $597,5342018Assets 2019: $38,989,543Liabilities 2019: $36,842,677Net Assets 2019: $2,146,8662019

Highlighted filing

2017

Assets$66,391,789
Liabilities$14,042,965
Net Assets$52,348,824

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100M$50M$0-$50MExpenses 2010: $35,920,9952010Revenue 2011: $18,181,537Expenses 2011: $37,226,565Net Income 2011: -$19,045,0282011Revenue 2012: $52,130,143Expenses 2012: $40,164,028Net Income 2012: $11,966,1152012Revenue 2013: $59,399,215Expenses 2013: $37,490,390Net Income 2013: $21,908,8252013Revenue 2014: $24,771,754Expenses 2014: $47,169,027Net Income 2014: -$22,397,2732014Revenue 2015: $46,734,872Expenses 2015: $38,397,069Net Income 2015: $8,337,8032015Revenue 2016: $5,990,503Expenses 2016: $42,072,773Net Income 2016: -$36,082,2702016Revenue 2017: $7,108,916Expenses 2017: $43,734,346Net Income 2017: -$36,625,4302017Revenue 2018: $35,807,318Expenses 2018: $35,391,575Net Income 2018: $415,7432018Revenue 2019: $10,961,263Expenses 2019: $9,746,391Net Income 2019: $1,214,8722019

Highlighted filing

2017

Revenue$7,108,916
Expenses$43,734,346
Net Income-$36,625,430
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Nov 12, 2018
Return Version
2017v2.3
Gross Receipts
$33,220,750
Mission and Program Overview

Mission

The mission of path vaccine solutions (pvs) is to improve the health of children in low-income countries by accelerating the development of vaccines that will be effective and affordable for those who need them most. From initial discovery through clinical trials, pvs works with commercial partners, such as vaccine manufacturers and biotechnology firms, and nonprofit partners, such as universities and research institutions, to shorten the timeline for vaccine development.pvs works with partners to develop new vaccines by providing funding and expertise in preclinical development, manufacturing, and clinical development, with a focus on low-resource countries. In return, partners agree to terms that help ensure the resulting products are affordable and available in developing countries.

SEE PART III, LINE 1.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$74,661,038$44,444,842▼ $30,216,196
Pledges and Grants Receivable$32,558,748$21,866,566▼ $10,692,182
Accounts Receivable$202,886$0▼ $202,886
Prepaid Expenses and Deferred Charges$70$56,033▲ $55,963
Land, Buildings, and Equipment, Net$42,765$24,348▼ $18,417
Total Assets$107,465,507$66,391,789▼ $41,073,718
Liabilities
Accounts Payable and Accrued Expenses$15,803,401$14,042,965▼ $1,760,436
Total Liabilities$15,803,401$14,042,965▼ $1,760,436
Net Assets / Fund Balance
Temporarily Rstr Net Assets$91,643,999$52,340,280▼ $39,303,719
Unrestricted Net Assets$18,107$8,544▼ $9,563
Total Net Assets Fund Balance$91,662,106$52,348,824▼ $39,313,282
Total Liabilities and Net Assets / Fund Balance$107,465,507$66,391,789▼ $41,073,718

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$24,348$236,662$261,010
Compensation and Service Providers

Board Members and Trustees

NameTitle
Stephen B DavisChair and President
Penny HeatonVice Chair
Amie E BatsonDirector
Chris KarpDirector
David C KaslowDirector
Daniel LasterSecretary
Olivia D PoliusTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$6,592,045
Program Service Revenue
$0
Investment Income
$504,329
Other Revenue
$12,542
All Other Contributions
$6,592,045
Change in Net Assets
$-36,625,430
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$30,367,803
Other Expenses$13,366,543
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$23,543,484--$23,543,484
Foreign Grants$6,824,319--$6,824,319
Travel$1,193,427--$1,193,427
Fees for Services Other$381,903--$381,903
Office Expenses$236,297--$236,297
Conferences and Meetings$88,630--$88,630
Other Expenses$79,561--$79,561
Depreciation Depletion$45,152--$45,152
Fees for Service Investment Mgmnt Fees$40,554--$40,554
Insurance$37,525--$37,525
Information Technology$34,168--$34,168
All Other Expenses$7,859--$7,859
Fees for Services Legal$6,246--$6,246
Advertising$4,433--$4,433
Royalties$2,500--$2,500
Fees for Services Accounting$1,664--$1,664
Total Functional Expenses$43,734,346$0$0$43,734,346
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
PathSeattle, WA501(c)(3)Product Development$15,312,358
Infectious Disease Research InstituteSeattle, WA501(c)(3)Product Development$1,343,203
Advanced Bioscience Laboratories IncRockville, MDN/aProduct Development$1,148,163
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTERCincinnati, OH501(c)(3)Product Development$882,368
University of Maryland School of Medicine Center for Vaccine DevelopmentBaltimore, MD501(c)(3)Product Development$873,058
United States Naval Medical Research CenterSilver Spring, MDGovProduct Development$858,868
Walter Reed Army Institute of ResearchSilver Spring, MDGovProduct Development$590,550
Henry M Jackson Foundation for the Advancement of Military MedicineBethesda, MD501(c)(3)Product Development$497,310
BOSTON CHILDREN'S HOSPITALBoston, MA501(c)(3)Product Development$340,000
Johns Hopkins UniversityBaltimore, MD501(c)(3)Product Development$326,104
University of Maryland BaltimoreBaltimore, MD501(c)(3)Product Development$265,356
Immport Therapeutics IncIrvine, CAN/aProduct Development$234,526
Jhu Bloomberg School of Public HealthBaltimore, MD501(c)(3)Product Development$225,584
Icahn School of Medicine at Mount SinaiNew York, NY501(c)(3)Product Development$224,000
Kansas State UniversityManhattan, KS501(c)(3)Product Development$169,560
Lankenau Institute for Medical ResearchWynnewood, PA501(c)(3)Product Development$81,668
Food & Drug AdministrationSilver Spring, MDGovProduct Development$80,000
Tulane Educational FundNew Orleans, LA501(c)(3)Product Development$58,060
Family Health International 360Durham, NC501(c)(3)Product Development$31,230
University of Kansas Center for Research IncLawrence, KS501(c)(3)Product Development$18,000
Board of Trustees of the University of AlabamaBirmingham, AL501(c)(3)Product Development$-16,482

International Summary

Offices
0
Employees
6
Spending
$9,375,774

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
EuropeGrantmakingEssential Medicine00$4,535,641
South AsiaGrantmaking-00$1,422,862
South AsiaProgram ServicesEssential Medicine05$1,062,217
Sub-saharan AfricaProgram Services-01$755,150
Sub-saharan AfricaGrantmaking-00$633,262
EuropeProgram ServicesEssential Medicine00$573,248
East Asia and the PacificGrantmakingEssential Medicine00$232,554
East Asia and the PacificProgram ServicesEssential Medicine00$136,360
North AmericaProgram ServicesEssential Medicine00$15,192
South AmericaProgram ServicesEssential Medicine00$7,589
Middle East and North AfricaProgram Services-00$1,699
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

The form 990 was prepared by an outside accounting firm (gelman, rosenberg & freedman, cpas), using information provided by path accounting services staff. Path senior management reviewed the draft form. A copy of the draft was sent to pvs's board of directors for comment. After the comment period, the chief financial officer signed and filed the return.

Form 990, Part VI, Section B, Line 12C

Pvs has a written conflict of interest policy under which all pvs board members and officers must annually complete a conflict of interest disclosure form. Pvs does not have employees. Pvs is a supporting organization to path within the meaning of internal revenue code section 509(a)(3) and contracts with path for management services. Path has a written conflict of interest policy under which all path board members, officers, and staff at higher than a designated level must annually complete a conflict of interest disclosure form. All pvs and path disclosure forms are reviewed and kept on file. A conflict management plan is developed for any employee with a significant actual or perceived conflict of interest. Path also has a well-defined procedure for identifying and reporting actual and potential conflicts of interest among board members. New board members are asked to complete a conflict of interest disclosure form within 30 days of joining the board and to complete a new form annually thereafter. In addition, members are reminded to report any new issues that arise outside of the annual disclosure period. The disclosure forms are reviewed by path's general counsel, and if any actual or potential conflicts are identified, general counsel makes a recommendation to the chair of the governance committee and the chair of the board for a management plan to properly manage any conflicts. A formal management plan is then agreed upon with the board member, and the entire board of directors is informed at the next regularly scheduled board meeting.

Form 990, Part VI, Section C, Line 19

Pvs's governing documents, conflict of interest policy, and financial statements are available to the public upon request; most documents are also available online.

Filing and Contact Details

Filer

Filer Name
Path Vaccine Solutions
EIN
83-0431851
Phone
2062853500
Address
2201 WESTLAKE AVENUE NO 200, SEATTLE, WA 98121

Signing Officer

Name
Olivia D Polius
Title
Chief Financial Officer
Phone
2062853500
Signed
2018-11-12
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Olivia D Polius
Formed
2006
Legal Domicile
Wa
Voting Board Members
7
Independent Board Members
2
Employees
0
Volunteers
0

Preparer

Firm
Gelman Rosenberg & Freedman
Address
4550 MONTGOMERY AVE SUITE 650N, BETHESDA, MD 20814-2930
Phone
3019519090
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

From time to time, unspent award funds (or unused obligations) may be returned to a funder for a variety of reasons including, but not limited to, early termination of a project by a funder or a reduction in funds required to accomplish a project's scope of work. -2,774,174.

Raw XML AppendixShowing 400 of 910 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt015803401
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt014042965
IRS990/AccountsReceivableGrp/BOYAmt0202886
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE PART III, LINE 1.
IRS990/AdvertisingGrp/ProgramServicesAmt04433
IRS990/AdvertisingGrp/TotalAmt04433
IRS990/AllOtherContributionsAmt06592045
IRS990/AllOtherExpensesGrp/ProgramServicesAmt07859
IRS990/AllOtherExpensesGrp/TotalAmt07859
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0OLIVIA POLIUS CHIEF FINANCIAL OFFICER
IRS990/BooksInCareOfDetail/PhoneNum02062853500
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02201 WESTLAKE AVE SUITE 200
IRS990/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd098121
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt088630
IRS990/ConferencesMeetingsGrp/TotalAmt088630
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt06592045
IRS990/CYGrantsAndSimilarPaidAmt030367803
IRS990/CYInvestmentIncomeAmt0504329
IRS990/CYOtherExpensesAmt013366543
IRS990/CYOtherRevenueAmt012542
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-36625430
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt043734346
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt07108916
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ProgramServicesAmt045152
IRS990/DepreciationDepletionGrp/TotalAmt045152
IRS990/Desc0PVS WORKS TO PREVENT DEATH AND DISEASE CAUSED BY DIARRHEA, PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, AND POLIO AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2017, PVS CONTINUED OUR FIGHT AGAINST DIARRHEAL DISEASES, THE SECOND LEADING CAUSE OF DEATH AMONG CHILDREN IN LOW-INCOME COUNTRIES. TO COMBAT ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, WE CONTINUED CLINICAL DEVELOPMENT OF A NONREPLICATING ROTAVIRUS VACCINE CANDIDATE. THIS TYPE OF ROTAVIRUS VACCINE WOULD BE ADMINISTERED AS AN INTRAMUSCULAR INJECTION AND COULD POTENTIALLY OVERCOME THE LOWER EFFICACY LEVELS SEEN IN LOW-RESOURCE SETTINGS FOR ORAL, LIVE, ATTENUATED VACCINES. WE ALSO COMPLETED A STUDY WITH SERUM INSTITUTE OF INDIA PVT. LTD. (SIIPL) OF A ROTAVIRUS VACCINE ABLE TO REMAIN STABLE AND POTENT DURING EXTENDED PERIODS WITHOUT REFRIGERATION, ENABLING WIDER USE IN REMOTE COMMUNITIES. IN SEPTEMBER 2017, THE GOVERNMENT OF INDIA ORDERED SIIPL'S VACCINE, ROTASIIL, FOR USE IN THE COUNTRY'S UNIVERSAL IMMUNIZATION PROGRAM. IN ADDITION, ROTAVAC, ANOTHER INDIAN-MADE VACCINE DEVELOPED WITH PATH SUPPORT, ADVANCED TOWARD WORLD HEALTH ORGANIZATION PREQUALIFICATION. WE CONTINUED TO CONDUCT EARLY-STAGE CLINICAL TRIALS OF VACCINE CANDIDATES THAT MAY PROVIDE PROTECTION AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) AND SHIGELLA, LEADING CAUSES OF BACTERIAL DIARRHEAL ILLNESS. CURRENTLY, THERE ARE NO LICENSED VACCINES AGAINST EITHER PATHOGEN. WE ALSO ADVANCED DEVELOPMENT OF LOW-COST VACCINE CANDIDATES TO PROTECT CHILDREN AGAINST PNEUMOCOCCAL BACTERIA, THE TOP CAUSE OF SEVERE CHILDHOOD PNEUMONIA. IN 2017, WE BEGAN A PHASE 3 STUDY IN THE GAMBIA TO EVALUATE A PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) CANDIDATE DESIGNED TO BE AFFORDABLE AND TO PROVIDE PROTECTION AGAINST TEN BACTERIAL SEROTYPES THAT CAUSE MOST CASES OF INVASIVE PNEUMOCOCCAL DISEASE IN AFRICA AND ASIA. IN KENYA, WE STUDIED A VACCINE CANDIDATE WITH THE POTENTIAL TO PROVIDE LOW-COST, BROAD PROTECTION ACROSS MANY SEROTYPES.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt043734346
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt01664
IRS990/FeesForServicesAccountingGrp/TotalAmt01664
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt06246
IRS990/FeesForServicesLegalGrp/TotalAmt06246
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0381903
IRS990/FeesForServicesOtherGrp/TotalAmt0381903
IRS990/FeesForSrvcInvstMgmntFeesGrp/ProgramServicesAmt040554
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt040554
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt06824319
IRS990/ForeignGrantsGrp/TotalAmt06824319
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt039.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt239.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt339.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt439.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt539.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt065784
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt253104
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt341018
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt427395
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt567708
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/PersonNm0STEPHEN B DAVIS
IRS990/Form990PartVIISectionAGrp/PersonNm1PENNY HEATON
IRS990/Form990PartVIISectionAGrp/PersonNm2OLIVIA D POLIUS
IRS990/Form990PartVIISectionAGrp/PersonNm3DANIEL LASTER
IRS990/Form990PartVIISectionAGrp/PersonNm4AMIE E BATSON
IRS990/Form990PartVIISectionAGrp/PersonNm5DAVID C KASLOW
IRS990/Form990PartVIISectionAGrp/PersonNm6CHRIS KARP
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0641522
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2311327
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3334058
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4312831
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt5368007
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIR AND PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02006
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0-142014
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt030367803
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt023543484
IRS990/GrantsToDomesticOrgsGrp/TotalAmt023543484
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt025969820
IRS990/GrossReceiptsAmt033220750
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt034168
IRS990/InformationTechnologyGrp/TotalAmt034168
IRS990/InsuranceGrp/ProgramServicesAmt037525
IRS990/InsuranceGrp/TotalAmt037525
IRS990/InvestmentIncomeGrp/ExclusionAmt0646343
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0646343
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt074661038
IRS990/InvestmentsPubTradedSecGrp/EOYAmt044444842
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0236662
IRS990/LandBldgEquipBasisNetGrp/BOYAmt042765
IRS990/LandBldgEquipBasisNetGrp/EOYAmt024348
IRS990/LandBldgEquipCostOrOtherBssAmt0261010
IRS990/LegalDomicileStateCd0WA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt026111834
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE FOR THOSE WHO NEED THEM MOST.FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.PVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN PRECLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-RESOURCE COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT HELP ENSURE THE RESULTING PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt091662106
IRS990/NetAssetsOrFundBalancesEOYAmt052348824
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-142014
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-142014
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt086322
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ProgramServicesAmt0236297
IRS990/OfficeExpensesGrp/TotalAmt0236297
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-2774174
IRS990/OtherExpensesGrp/Desc0SUBCONTRACTORS
IRS990/OtherExpensesGrp/Desc1LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc2STORAGE
IRS990/OtherExpensesGrp/Desc3EQUIPMENT R&M
IRS990/OtherExpensesGrp/ProgramServicesAmt010885797
IRS990/OtherExpensesGrp/ProgramServicesAmt1235358
IRS990/OtherExpensesGrp/ProgramServicesAmt285469
IRS990/OtherExpensesGrp/ProgramServicesAmt379561
IRS990/OtherExpensesGrp/TotalAmt010885797
IRS990/OtherExpensesGrp/TotalAmt1235358
IRS990/OtherExpensesGrp/TotalAmt285469
IRS990/OtherExpensesGrp/TotalAmt379561
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0OTHER REIMBURSEMENTS
IRS990/OtherRevenueMiscGrp/ExclusionAmt012542
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt012542
IRS990/OtherRevenueTotalAmt012542
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt032558748
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt021866566
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt070
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt056033
IRS990/PrincipalOfficerNm0OLIVIA D POLIUS
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt04727165
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt029855678
IRS990/PYInvestmentIncomeAmt01239778
IRS990/PYOtherExpensesAmt012217095
IRS990/PYOtherRevenueAmt023560
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-36082270
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt042072773
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt05990503
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-36625430
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RoyaltiesGrp/ProgramServicesAmt02500
IRS990/RoyaltiesGrp/TotalAmt02500
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0911157127
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt043734346
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0PATH
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt043734346
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/EquipmentGrp/BookValueAmt024348
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0236662
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0261010
IRS990ScheduleD/TotalBookValueLandBuildingsAmt024348
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt65
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt81
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt90
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt100
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt20
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt30
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt40
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt50
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt60
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt70
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt80
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt90
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt100
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt0136360
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt1232554
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt2573248
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt34535641
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt415192
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt57589
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt61062217
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt71422862
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt8755150
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt9633262
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt101699
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EAST ASIA AND THE PACIFIC
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt2EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt3EUROPE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt4NORTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt5SOUTH AMERICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt6SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt7SOUTH ASIA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt8SUB-SAHARAN AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt9SUB-SAHARAN AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt10MIDDLE EAST AND NORTH AFRICA
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt0ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt1ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt2ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt3ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt4ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt5ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/SpecificServicesProvidedTxt6ESSENTIAL MEDICINE
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt2PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt3GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt4PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt5PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt6PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt7GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt8PROGRAM SERVICES
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt9GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt10PROGRAM SERVICES
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt01390111
IRS990ScheduleF/ContinuationTotalEmployeeCnt01
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt0318406
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt15161
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt2908727
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt3180469
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt497929
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt5463425
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt6242865
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt720619
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt81402243
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt952085
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt1074902
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt112235000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt12265851
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt1359816
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt14200000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt1550000
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt1626118
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt17142190
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt18225221
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt19-247717
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt20-32963
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt21-12796
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt22146769
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt1CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt2CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt3CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt4CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt5CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt6CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt7CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt8CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt9CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt10CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt11CHECK/WIRE
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt12CHECK/WIRE

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2017 filings • 501(c)3 • $50M-$100M nonprofits